The mRNA expression of DAP1 in human breast cancer: Correlation with clinicopathological parameters

Cancer Genomics and Proteomics

Volumn 9, Issue 4, 2012, Pages 199-201

  Wazir, U ^a   Jiang, W G ^b   Sharma, A K ^a   Mokbel, Kefah ^a,c  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^b CARDIFF UNIVERSITY SCHOOL OF MEDICINE   (United Kingdom)

^c Princess Grace Hospital   (United Kingdom)

Author keywords

Apoptosis; Autophagy; Breast cancer; DAP1; PCR; Tumour suppressor gene

Indexed keywords

DEATH-ASSOCIATED PROTEIN 1; MESSENGER RNA; PHOSPHOPROTEIN; UNCLASSIFIED DRUG;

ARTICLE; BREAST CANCER; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER STAGING; CONTROLLED STUDY; CORRELATION ANALYSIS; DISTANT METASTASIS; FOLLOW UP; HUMAN; HUMAN TISSUE; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; NOTTINGHAM PROGNOSTIC INDEX; OUTCOME ASSESSMENT; PILOT STUDY; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS;

EID: 84864652347     PISSN: 11096535     EISSN: 17906245     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. May P and May E: Twenty years of p53 research: structural and functional aspects of the p53 protein. Oncogene 18: 7621-7636, 1999. (Pubitemid 30052689)
2. Basu A and Haldar S: The relationship between BcI2, Bax and p53: consequences for cell cycle progression and cell death. Mol Hum Reprod 4: 1099-1109, 1998. (Pubitemid 28552792)
3. Cohen GM: Caspases: the executioners of apoptosis. Biochem J 326(Pt 1): 1-16, 1997.
4. Elmore S: Apoptosis: a review of programmed cell death. Toxicol Pathol 35: 495-516, 2007.
5. Rastogi RP, Sinha R and Sinha RP: Apoptosis: Molecular mechanisms and pathogenicity. EXCLI J 8: 155-181, 2009.
6. Levy-Strumpf N and Kimchi A: Death-associated proteins (DAPs): from gene identification to the analysis of their apoptotic and tumor suppressive functions. Oncogene 17: 3331-3340, 1998. (Pubitemid 29043985)
7. Koren I, Reem E and Kimchi A: Autophagy gets a brake: DAP1, a novel mTOR substrate, is activated to suppress the autophagic process. Autophagy 6: 1179-1180, 2010.
8. Al Sarakbi W, Sasi W, Jiang WG, Roberts T, Newbold RF and Mokbel K: The mRNA expression of SETD2 in human breast cancer: correlation with clinicopathological parameters. BMC Cancer 9: 290, 2009.
9. Chong YM, Colston K, Jiang WG, Sharma AK and Mokbel K: The relationship between the insulin-like growth factor-1 system and the oestrogen-metabolising enzymes in breast cancer tissue and its adjacent non-cancerous tissue. Breast Cancer Res Treat 99: 275-288, 2006. (Pubitemid 44337919)
10. HGNC Database, HUGO Gene Nomenclature Committee (HGNC), EMBL Outstation - Hinxton, European Bioinformatics Institute, Wellcome Trust Genome Campus, Hinxton, Cambridgeshire, CB101SD, UK. www.genenames.org. Accessed April 2012.
11. Wazir U, Jiang WG, Sharma AK and Mokbel K: The mRNA expression of DAP3 in human breast cancer: Correlation with clinicopathological parameters. Anticancer Res 32: 671-674, 2012.
12. Koren I, Reem E and Kimchi A: DAP1, a novel substrate of mTOR, negatively regulates autophagy. Curr Biol 20: 1093-1098, 2010.
13. Laplante M and Sabatini DM: mTOR signaling in growth control and disease. Cell 149: 274-293, 2012.